Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

REVCO IS FIRST CHAIN MEMBER OF PROPOSED NATIONWIDE PHARMACY PPO

Executive Summary

REVCO IS FIRST CHAIN MEMBER OF PROPOSED NATIONWIDE PHARMACY PPO organized by Mesa, Arizona-based First American Health Concepts (FAHC). In a May 6 press release, FAHC noted that the "first pharmaceutical provider that contracted to participate in the program was Revco Discount Drugs, America's largest retail drugstore chain, with over 2,000 outlets in 28 states." The program, known as "America's first Pharmacy Card" (APC), has "the need to contract with approximately 15,000 stores, in order to meet the access requirements of the company's APC sponsors," FAHC said. The group "is contacting retail organizations throughout the country, inviting their participation in the program," the company said. Among those being asked to participate are other chains and independent stores connected to state pharmacy service administrative organizations. Under the plan, pharmacists are paid a set fee by the APC cardholder at the time of purchase. The cardholder pays FAHC a "negotiated discount price" for the prescription at time of purchase. The negotiated discount is the average wholesale price or the usual and customary charge, whichever is less, explained Michael Comick, FAHC Director of Pharmaceutical Services. Subsequently, the client can receive reimbursement from his or her third party payor at the reimbursing group's prescribed percentage. Comick described the APC plan as "basically . . . a fee for service type of program for the pharmacist in that they're out of the loop financially after the individual has come in and received the product because [the client pays] the money up front." He added: "Pharmacists don't have to worry about claims processing . . . eligibility verification . . . [or] the float that seems to occur with alot of the third party payors who seem to be a little slower than they should be." The APC plan is still in the "developmental" stage, though cards have been distributed and will be accepted at Revco stores, according to Comick. Currently, the service is available to individual subscribers of 44 insurance organizations. Among carriers already contracting with FAHC are members of the company's initial health care cost containment venture, Eye Care Plan of America. Enrollees include Ohio State Life, American Continental Life, Best Life Assurance Company, and Allied Group Assurance Trust. In return for assuming the administrative responsibilities for the plan, FAHC is paid an enrollment fee from participating stores and a set monthly fee from member insurance companies and other sponsoring organizations.

You may also be interested in...



Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance

FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials

Shire Hopes To Sow Future Deals With $50M Venture Fund

Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth

UsernamePublicRestriction

Register

LL1135424

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel